Shopping Cart (Login required)

Cannabinoid Screening Optimized with ISOLUTE® SLE+

11 November 2016

A scalable high-throughput method for confirming cannabinoids in urine with ISOLUTE® SLE+ has been developed by the US National Institute on Drug Abuse (NIDA).


Chemists at NIDA have developed a non-targeted LC-QTOF acquisition method for confirming 47 synthetic cannabinoid metabolites in human urine. A review published on compares this optimized sample preparation with a previous method from 2013. The optimization was performed with Kura BG100® hydrolysis followed by ISOLUTE® SLE+ in order to “reduce costs and minimize instrument downtime”. With the upgrade, a high-throughput screening method was made possible. 

Download the report here »

More posters from Kura Biotec »

Featured Videos

ISOLUTE® SLE+ Supported Liquid Extraction